Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

2.205 -0.005 (-0.23%)

Streaming Delayed Price Updated: 3:59 PM EDT, Aug 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	478
Open	2.205
Bid (Size)	2.220 (100)
Ask (Size)	2.240 (300)
Prev. Close	2.210
Today's Range	2.205 - 2.205
52wk Range	1.170 - 2.710
Shares Outstanding	78,986,490
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Innate Pharma Secures €30M, Extends Cash Runway Into 2028 ↗

August 14, 2026

Innate Pharma (NASDAQ:IPHA) said it has raised €30 million in equity financing, providing funding to advance its strategic priorities, including the development of its lacutamab and IPH4502 programs...

Via MarketBeat

Innate Pharma Announces Conference Call and Webcast

August 14, 2026

From Innate Pharma SA

Via Business Wire

Performance

YTD	+21.2%	+21.2%
1 Month	+24.4%	+24.4%
3 Month	+28.2%	+28.2%
6 Month	+32.8%	+32.8%
1 Year	-1.6%	-1.6%

More News

Unusual volume stocks are being observed in Wednesday's session. ↗

August 12, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

August 11, 2026

Via Chartmill

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

August 10, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

August 10, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference

July 23, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)

July 21, 2026

From Innate Pharma SA

Via Business Wire

Outcome of Innate Pharma’s 2026 Annual General Meeting

May 22, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to participate in the Jefferies Global Healthcare Conference

May 19, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Q1 Earnings Call Highlights ↗

May 13, 2026

Via MarketBeat

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

May 13, 2026

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026

May 12, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update

May 06, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in the D. Boral Capital Global Conference

April 23, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026

April 17, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026

April 13, 2026

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

April 13, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event

April 08, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in the Kempen Life Sciences Conference

April 03, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report

April 02, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Reports Full Year 2025 Financial Results and Business Update

March 26, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

March 19, 2026

From Innate Pharma SA

Via Business Wire

Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026

February 19, 2026

From Innate Pharma SA

Via Business Wire

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

February 18, 2026

From Innate Pharma SA

Via Business Wire

Frequently Asked Questions

Is Innate Pharma S.A. - American Depositary Shares publicly traded?

Yes, Innate Pharma S.A. - American Depositary Shares is publicly traded.

What exchange does Innate Pharma S.A. - American Depositary Shares trade on?

Innate Pharma S.A. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Innate Pharma S.A. - American Depositary Shares?

The ticker symbol for Innate Pharma S.A. - American Depositary Shares is IPHA on the Nasdaq Stock Market

What is the current price of Innate Pharma S.A. - American Depositary Shares?

The current price of Innate Pharma S.A. - American Depositary Shares is 2.205

When was Innate Pharma S.A. - American Depositary Shares last traded?

The last trade of Innate Pharma S.A. - American Depositary Shares was at 08/24/26 03:59 PM ET

What is the market capitalization of Innate Pharma S.A. - American Depositary Shares?

The market capitalization of Innate Pharma S.A. - American Depositary Shares is 174.17M

How many shares of Innate Pharma S.A. - American Depositary Shares are outstanding?

Innate Pharma S.A. - American Depositary Shares has 174M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433